NYSE:AORT - New York Stock Exchange, Inc. - US2289031005 - Common Stock - Currency: USD
24.18
-0.53 (-2.14%)
The current stock price of AORT is 24.18 USD. In the past month the price decreased by -22.67%. In the past year, price increased by 20.78%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 29.37 | 237.84B | ||
ISRG | INTUITIVE SURGICAL INC | 70.7 | 184.84B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.49 | 146.29B | ||
SYK | STRYKER CORP | 31.12 | 144.73B | ||
MDT | MEDTRONIC PLC | 17.7 | 121.20B | ||
BDX | BECTON DICKINSON AND CO | 16.5 | 65.91B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.84 | 41.35B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 19.28 | 39.59B | ||
IDXX | IDEXX LABORATORIES INC | 38.23 | 34.98B | ||
RMD | RESMED INC | 26.29 | 34.14B | ||
DXCM | DEXCOM INC | 47.18 | 30.42B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 18.25 | 25.91B |
Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,500 full-time employees. The firm's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. The company has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. The company also sells or distributes PhotoFix bovine surgical patches.
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1500
Company Website: https://artivion.com/
Investor Relations: https://investors.artivion.com/
Phone: 17704193355
The current stock price of AORT is 24.18 USD. The price decreased by -2.14% in the last trading session.
The exchange symbol of ARTIVION INC is AORT and it is listed on the New York Stock Exchange, Inc. exchange.
AORT stock is listed on the New York Stock Exchange, Inc. exchange.
12 analysts have analysed AORT and the average price target is 32.98 USD. This implies a price increase of 36.39% is expected in the next year compared to the current price of 24.18. Check the ARTIVION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ARTIVION INC (AORT) has a market capitalization of 1.02B USD. This makes AORT a Small Cap stock.
ARTIVION INC (AORT) currently has 1500 employees.
The Revenue of ARTIVION INC (AORT) is expected to grow by 8.07% in the next year. Check the estimates tab for more information on the AORT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AORT does not pay a dividend.
ARTIVION INC (AORT) will report earnings on 2025-05-05, after the market close.
ARTIVION INC (AORT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.43).
The outstanding short interest for ARTIVION INC (AORT) is 10.57% of its float. Check the ownership tab for more information on the AORT short interest.
ChartMill assigns a technical rating of 1 / 10 to AORT. When comparing the yearly performance of all stocks, AORT turns out to be only a medium performer in the overall market: it outperformed 61.27% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to AORT. Both the profitability and the financial health of AORT get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of -0.43. The EPS increased by 41.89% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.69% | ||
ROE | -4.84% | ||
Debt/Equity | 1.15 |
ChartMill assigns a Buy % Consensus number of 87% to AORT. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 136.53% and a revenue growth 8.07% for AORT